The ethical case for placebo control in HIV-cure-related studies with ART interruption

Many studies that seek to cure HIV must ask participants to interrupt their antiretroviral treatment. In such circumstances, is it permissible to include a placebo group in the study? We explain why doing so is a scientific and an ethical necessity, and more benign than imagined.

Bibliographic Details
Main Authors: Monica Magalhaes, Daniel R. Kuritzkes, Nir Eyal
Format: Article
Language:English
Published: Elsevier 2022-09-01
Series:Journal of Virus Eradication
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S205566402200022X
_version_ 1798019920517136384
author Monica Magalhaes
Daniel R. Kuritzkes
Nir Eyal
author_facet Monica Magalhaes
Daniel R. Kuritzkes
Nir Eyal
author_sort Monica Magalhaes
collection DOAJ
description Many studies that seek to cure HIV must ask participants to interrupt their antiretroviral treatment. In such circumstances, is it permissible to include a placebo group in the study? We explain why doing so is a scientific and an ethical necessity, and more benign than imagined.
first_indexed 2024-04-11T16:49:14Z
format Article
id doaj.art-ba3d0be3fc9d4a0db364f45b13a41458
institution Directory Open Access Journal
issn 2055-6640
language English
last_indexed 2024-04-11T16:49:14Z
publishDate 2022-09-01
publisher Elsevier
record_format Article
series Journal of Virus Eradication
spelling doaj.art-ba3d0be3fc9d4a0db364f45b13a414582022-12-22T04:13:30ZengElsevierJournal of Virus Eradication2055-66402022-09-0183100084The ethical case for placebo control in HIV-cure-related studies with ART interruptionMonica Magalhaes0Daniel R. Kuritzkes1Nir Eyal2Center for Population-Level Bioethics, Rutgers University, New Brunswick, NJ, USA; Corresponding author.Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USACenter for Population-Level Bioethics, Rutgers University, New Brunswick, NJ, USA; Department of Philosophy, Rutgers University, New Brunswick, NJ, USA; Department of Health Behavior, Society, and Policy, Rutgers School of Public Health, Piscataway, NJ, USAMany studies that seek to cure HIV must ask participants to interrupt their antiretroviral treatment. In such circumstances, is it permissible to include a placebo group in the study? We explain why doing so is a scientific and an ethical necessity, and more benign than imagined.http://www.sciencedirect.com/science/article/pii/S205566402200022XHIV Cure-related studiesHuman subjects researchResearch ethicsAnalytic treatment interruptionPlacebos
spellingShingle Monica Magalhaes
Daniel R. Kuritzkes
Nir Eyal
The ethical case for placebo control in HIV-cure-related studies with ART interruption
Journal of Virus Eradication
HIV Cure-related studies
Human subjects research
Research ethics
Analytic treatment interruption
Placebos
title The ethical case for placebo control in HIV-cure-related studies with ART interruption
title_full The ethical case for placebo control in HIV-cure-related studies with ART interruption
title_fullStr The ethical case for placebo control in HIV-cure-related studies with ART interruption
title_full_unstemmed The ethical case for placebo control in HIV-cure-related studies with ART interruption
title_short The ethical case for placebo control in HIV-cure-related studies with ART interruption
title_sort ethical case for placebo control in hiv cure related studies with art interruption
topic HIV Cure-related studies
Human subjects research
Research ethics
Analytic treatment interruption
Placebos
url http://www.sciencedirect.com/science/article/pii/S205566402200022X
work_keys_str_mv AT monicamagalhaes theethicalcaseforplacebocontrolinhivcurerelatedstudieswithartinterruption
AT danielrkuritzkes theethicalcaseforplacebocontrolinhivcurerelatedstudieswithartinterruption
AT nireyal theethicalcaseforplacebocontrolinhivcurerelatedstudieswithartinterruption
AT monicamagalhaes ethicalcaseforplacebocontrolinhivcurerelatedstudieswithartinterruption
AT danielrkuritzkes ethicalcaseforplacebocontrolinhivcurerelatedstudieswithartinterruption
AT nireyal ethicalcaseforplacebocontrolinhivcurerelatedstudieswithartinterruption